menu search

Galapagos shares down after announcing clinical-trial miss for crohn's disease

U.S.-listed shares of Galapagos GLPG, +0.41% were down 8.9% in premarket trading on Thursday, the day after the company said an experimental treatment...

February 9, 2023, 8:35 am

Sorrento to host webcast to discuss newly presented clinical data demonstrating significant improvements in therapeutic outcomes in 10 of 10 patients with poorly controlled rheumatoid arthritis

ATLANTA and SAN DIEGO, Nov. 13, 2022 (GLOBE NEWSWIRE) — Sofusa®, a wholly-owned division of Sorrento Therapeutics (Nasdaq: SRNE, “Sorrento”), t...

November 13, 2022, 8:02 pm

Sorrento to host webcast to discuss newly presented clinical data demonstrating significant improvements in therapeutic outcomes in 10 of 10 patients with poorly controlled rheumatoid arthritis

ATLANTA and SAN DIEGO, Nov. 13, 2022 (GLOBE NEWSWIRE) -- Sofusa®, a wholly-owned division of Sorrento Therapeutics (Nasdaq: SRNE, “Sorrento”), to...

November 13, 2022, 3:02 pm

Abbvie misses quarterly sales estimates as humira rivals bite

AbbVie Inc missed Wall Street estimates for first-quarter sales on Friday, hurt by European competition for its blockbuster ...

April 29, 2022, 7:49 am

Vyne therapeutics shares jump on encouraging preclinical data from vyn201 program in rheumatoid arthritis

VYNE Therapeutics Inc (NASDAQ: VYNE) announced positive preclinical data from its VYN201 program in the rhe...

March 30, 2022, 11:43 am

Abbvie's stock gains on fourth-quarter earnings as it reports better-than-expected sales of humana

Shares of AbbVie Inc. ABBV, +0.08% gained 1.4% in premarket trading on Wednesday after the company beat earnings expectations and generated more sales...

February 2, 2022, 8:06 am

Abbvie's stock gains on fourth-quarter earnings as it reports better-than-expected sales of humana

Shares of AbbVie Inc. ABBV, +0.08% gained 1.4% in premarket trading on Wednesday after the company beat earnings expectations and generated more sales...

February 2, 2022, 8:06 am

Abbvie's stock gains on fourth-quarter earnings as it reports better-than-expected sales of humana

Shares of AbbVie Inc. ABBV, +0.08% gained 1.4% in premarket trading on Wednesday after the company beat earnings expectations and generated more sales...

February 2, 2022, 8:06 am

Earnings outlook: what's next for a j&j that will soon be split into two different companies

Johnson & Johnson JNJ, +0.74% has long been viewed as a bellwether stock for other health care companies, given its early slot in the earnings calenda...

January 19, 2022, 12:02 pm

Earnings outlook: what's next for a j&j that will soon be split into two different companies

Johnson & Johnson JNJ, +0.74% has long been viewed as a bellwether stock for other health care companies, given its early slot in the earnings calenda...

January 19, 2022, 12:02 pm

Earnings outlook: what's next for a j&j that will soon be split into two different companies

Johnson & Johnson JNJ, +0.74% has long been viewed as a bellwether stock for other health care companies, given its early slot in the earnings calenda...

January 19, 2022, 12:02 pm

Clingen to distribute humanigen covid treatment in europe through managed access

Clinigen Group has set up an exclusive managed access program in Europe for Humanigen's anti-inflammatory drug lenzilumab. Humanigen is developing le...

October 8, 2021, 3:29 am

Clingen to distribute humanigen covid treatment in europe through managed access

Clinigen Group has set up an exclusive managed access program in Europe for Humanigen's anti-inflammatory drug lenzilumab. Humanigen is developing le...

October 8, 2021, 3:29 am

Clingen to distribute humanigen covid treatment in europe through managed access

Clinigen Group has set up an exclusive managed access program in Europe for Humanigen's anti-inflammatory drug lenzilumab. Humanigen is developing le...

October 8, 2021, 3:29 am


Search within

Pages Search Results: